Global Pharma Forecasting Software 麻豆原创 Growth (Status and Outlook) 2025-2031

Publication ID:

LPI06253909

Publication Date:

June 20, 2025

Pages:

133

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Software [3]

Computing & Electronics [4]

Description:

The global Pharma Forecasting Software market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
United States market for Pharma Forecasting Software is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Pharma Forecasting Software is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Pharma Forecasting Software is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Pharma Forecasting Software players cover IQVIA, JMP, SAS Institute, Oracle, Inpharmation, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淧harma Forecasting Software Industry Forecast鈥� looks at past sales and reviews total world Pharma Forecasting Software sales in 2024, providing a comprehensive analysis by region and market sector of projected Pharma Forecasting Software sales for 2025 through 2031. With Pharma Forecasting Software sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharma Forecasting Software industry.
This Insight Report provides a comprehensive analysis of the global Pharma Forecasting Software landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Pharma Forecasting Software portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Pharma Forecasting Software market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharma Forecasting Software and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharma Forecasting Software.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharma Forecasting Software market by product type, application, key players and key regions and countries.
Segmentation by Type:
Stability Prediction
Formulation and Process Development
Other
Segmentation by Application:
Pharmaceutical Companies
Contract Research Organizations (CROs)
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
IQVIA
JMP
SAS Institute
Oracle
Inpharmation
J+D Forecasting
ZS Associate
Cognizant
Kinaxis
Axtria
Symphony Health
Manthan
Model N
Sarjen
Koerber Pharma
WNS
SoftGroup
Nanjing Haiwei Pharmaceutical Technology

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Pharma Forecasting Software 麻豆原创 Size (2020-2031)
2.1.2 Pharma Forecasting Software 麻豆原创 Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Pharma Forecasting Software by Country/Region (2020, 2024 & 2031)
2.2 Pharma Forecasting Software Segment by Type
2.2.1 Stability Prediction
2.2.2 Formulation and Process Development
2.2.3 Other
2.3 Pharma Forecasting Software 麻豆原创 Size by Type
2.3.1 Pharma Forecasting Software 麻豆原创 Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Pharma Forecasting Software 麻豆原创 Size 麻豆原创 Share by Type (2020-2025)
2.4 Pharma Forecasting Software Segment by Application
2.4.1 Pharmaceutical Companies
2.4.2 Contract Research Organizations (CROs)
2.4.3 Other
2.5 Pharma Forecasting Software 麻豆原创 Size by Application
2.5.1 Pharma Forecasting Software 麻豆原创 Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Pharma Forecasting Software 麻豆原创 Size 麻豆原创 Share by Application (2020-2025)
3 Pharma Forecasting Software 麻豆原创 Size by Player
3.1 Pharma Forecasting Software 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Pharma Forecasting Software Revenue by Player (2020-2025)
3.1.2 Global Pharma Forecasting Software Revenue 麻豆原创 Share by Player (2020-2025)
3.2 Global Pharma Forecasting Software Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Pharma Forecasting Software by Region
4.1 Pharma Forecasting Software 麻豆原创 Size by Region (2020-2025)
4.2 Global Pharma Forecasting Software Annual Revenue by Country/Region (2020-2025)
4.3 Americas Pharma Forecasting Software 麻豆原创 Size Growth (2020-2025)
4.4 APAC Pharma Forecasting Software 麻豆原创 Size Growth (2020-2025)
4.5 Europe Pharma Forecasting Software 麻豆原创 Size Growth (2020-2025)
4.6 Middle East & Africa Pharma Forecasting Software 麻豆原创 Size Growth (2020-2025)
5 Americas
5.1 Americas Pharma Forecasting Software 麻豆原创 Size by Country (2020-2025)
5.2 Americas Pharma Forecasting Software 麻豆原创 Size by Type (2020-2025)
5.3 Americas Pharma Forecasting Software 麻豆原创 Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharma Forecasting Software 麻豆原创 Size by Region (2020-2025)
6.2 APAC Pharma Forecasting Software 麻豆原创 Size by Type (2020-2025)
6.3 APAC Pharma Forecasting Software 麻豆原创 Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Pharma Forecasting Software 麻豆原创 Size by Country (2020-2025)
7.2 Europe Pharma Forecasting Software 麻豆原创 Size by Type (2020-2025)
7.3 Europe Pharma Forecasting Software 麻豆原创 Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pharma Forecasting Software by Region (2020-2025)
8.2 Middle East & Africa Pharma Forecasting Software 麻豆原创 Size by Type (2020-2025)
8.3 Middle East & Africa Pharma Forecasting Software 麻豆原创 Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Pharma Forecasting Software 麻豆原创 Forecast
10.1 Global Pharma Forecasting Software Forecast by Region (2026-2031)
10.1.1 Global Pharma Forecasting Software Forecast by Region (2026-2031)
10.1.2 Americas Pharma Forecasting Software Forecast
10.1.3 APAC Pharma Forecasting Software Forecast
10.1.4 Europe Pharma Forecasting Software Forecast
10.1.5 Middle East & Africa Pharma Forecasting Software Forecast
10.2 Americas Pharma Forecasting Software Forecast by Country (2026-2031)
10.2.1 United States 麻豆原创 Pharma Forecasting Software Forecast
10.2.2 Canada 麻豆原创 Pharma Forecasting Software Forecast
10.2.3 Mexico 麻豆原创 Pharma Forecasting Software Forecast
10.2.4 Brazil 麻豆原创 Pharma Forecasting Software Forecast
10.3 APAC Pharma Forecasting Software Forecast by Region (2026-2031)
10.3.1 China Pharma Forecasting Software 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Pharma Forecasting Software Forecast
10.3.3 Korea 麻豆原创 Pharma Forecasting Software Forecast
10.3.4 Southeast Asia 麻豆原创 Pharma Forecasting Software Forecast
10.3.5 India 麻豆原创 Pharma Forecasting Software Forecast
10.3.6 Australia 麻豆原创 Pharma Forecasting Software Forecast
10.4 Europe Pharma Forecasting Software Forecast by Country (2026-2031)
10.4.1 Germany 麻豆原创 Pharma Forecasting Software Forecast
10.4.2 France 麻豆原创 Pharma Forecasting Software Forecast
10.4.3 UK 麻豆原创 Pharma Forecasting Software Forecast
10.4.4 Italy 麻豆原创 Pharma Forecasting Software Forecast
10.4.5 Russia 麻豆原创 Pharma Forecasting Software Forecast
10.5 Middle East & Africa Pharma Forecasting Software Forecast by Region (2026-2031)
10.5.1 Egypt 麻豆原创 Pharma Forecasting Software Forecast
10.5.2 South Africa 麻豆原创 Pharma Forecasting Software Forecast
10.5.3 Israel 麻豆原创 Pharma Forecasting Software Forecast
10.5.4 Turkey 麻豆原创 Pharma Forecasting Software Forecast
10.6 Global Pharma Forecasting Software Forecast by Type (2026-2031)
10.7 Global Pharma Forecasting Software Forecast by Application (2026-2031)
10.7.1 GCC Countries 麻豆原创 Pharma Forecasting Software Forecast
11 Key Players Analysis
11.1 IQVIA
11.1.1 IQVIA Company Information
11.1.2 IQVIA Pharma Forecasting Software Product Offered
11.1.3 IQVIA Pharma Forecasting Software Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.1.4 IQVIA Main Business Overview
11.1.5 IQVIA Latest Developments
11.2 JMP
11.2.1 JMP Company Information
11.2.2 JMP Pharma Forecasting Software Product Offered
11.2.3 JMP Pharma Forecasting Software Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.2.4 JMP Main Business Overview
11.2.5 JMP Latest Developments
11.3 SAS Institute
11.3.1 SAS Institute Company Information
11.3.2 SAS Institute Pharma Forecasting Software Product Offered
11.3.3 SAS Institute Pharma Forecasting Software Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.3.4 SAS Institute Main Business Overview
11.3.5 SAS Institute Latest Developments
11.4 Oracle
11.4.1 Oracle Company Information
11.4.2 Oracle Pharma Forecasting Software Product Offered
11.4.3 Oracle Pharma Forecasting Software Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.4.4 Oracle Main Business Overview
11.4.5 Oracle Latest Developments
11.5 Inpharmation
11.5.1 Inpharmation Company Information
11.5.2 Inpharmation Pharma Forecasting Software Product Offered
11.5.3 Inpharmation Pharma Forecasting Software Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.5.4 Inpharmation Main Business Overview
11.5.5 Inpharmation Latest Developments
11.6 J+D Forecasting
11.6.1 J+D Forecasting Company Information
11.6.2 J+D Forecasting Pharma Forecasting Software Product Offered
11.6.3 J+D Forecasting Pharma Forecasting Software Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.6.4 J+D Forecasting Main Business Overview
11.6.5 J+D Forecasting Latest Developments
11.7 ZS Associate
11.7.1 ZS Associate Company Information
11.7.2 ZS Associate Pharma Forecasting Software Product Offered
11.7.3 ZS Associate Pharma Forecasting Software Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.7.4 ZS Associate Main Business Overview
11.7.5 ZS Associate Latest Developments
11.8 Cognizant
11.8.1 Cognizant Company Information
11.8.2 Cognizant Pharma Forecasting Software Product Offered
11.8.3 Cognizant Pharma Forecasting Software Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.8.4 Cognizant Main Business Overview
11.8.5 Cognizant Latest Developments
11.9 Kinaxis
11.9.1 Kinaxis Company Information
11.9.2 Kinaxis Pharma Forecasting Software Product Offered
11.9.3 Kinaxis Pharma Forecasting Software Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.9.4 Kinaxis Main Business Overview
11.9.5 Kinaxis Latest Developments
11.10 Axtria
11.10.1 Axtria Company Information
11.10.2 Axtria Pharma Forecasting Software Product Offered
11.10.3 Axtria Pharma Forecasting Software Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.10.4 Axtria Main Business Overview
11.10.5 Axtria Latest Developments
11.11 Symphony Health
11.11.1 Symphony Health Company Information
11.11.2 Symphony Health Pharma Forecasting Software Product Offered
11.11.3 Symphony Health Pharma Forecasting Software Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.11.4 Symphony Health Main Business Overview
11.11.5 Symphony Health Latest Developments
11.12 Manthan
11.12.1 Manthan Company Information
11.12.2 Manthan Pharma Forecasting Software Product Offered
11.12.3 Manthan Pharma Forecasting Software Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.12.4 Manthan Main Business Overview
11.12.5 Manthan Latest Developments
11.13 Model N
11.13.1 Model N Company Information
11.13.2 Model N Pharma Forecasting Software Product Offered
11.13.3 Model N Pharma Forecasting Software Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.13.4 Model N Main Business Overview
11.13.5 Model N Latest Developments
11.14 Sarjen
11.14.1 Sarjen Company Information
11.14.2 Sarjen Pharma Forecasting Software Product Offered
11.14.3 Sarjen Pharma Forecasting Software Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.14.4 Sarjen Main Business Overview
11.14.5 Sarjen Latest Developments
11.15 Koerber Pharma
11.15.1 Koerber Pharma Company Information
11.15.2 Koerber Pharma Pharma Forecasting Software Product Offered
11.15.3 Koerber Pharma Pharma Forecasting Software Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.15.4 Koerber Pharma Main Business Overview
11.15.5 Koerber Pharma Latest Developments
11.16 WNS
11.16.1 WNS Company Information
11.16.2 WNS Pharma Forecasting Software Product Offered
11.16.3 WNS Pharma Forecasting Software Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.16.4 WNS Main Business Overview
11.16.5 WNS Latest Developments
11.17 SoftGroup
11.17.1 SoftGroup Company Information
11.17.2 SoftGroup Pharma Forecasting Software Product Offered
11.17.3 SoftGroup Pharma Forecasting Software Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.17.4 SoftGroup Main Business Overview
11.17.5 SoftGroup Latest Developments
11.18 Nanjing Haiwei Pharmaceutical Technology
11.18.1 Nanjing Haiwei Pharmaceutical Technology Company Information
11.18.2 Nanjing Haiwei Pharmaceutical Technology Pharma Forecasting Software Product Offered
11.18.3 Nanjing Haiwei Pharmaceutical Technology Pharma Forecasting Software Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.18.4 Nanjing Haiwei Pharmaceutical Technology Main Business Overview
11.18.5 Nanjing Haiwei Pharmaceutical Technology Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.